Evidence for long-term IVIg treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Commentary

Nature Clinical Practice Neurology

Volumn 4, Issue 7, 2008, Pages 352-353

  Nobile Orazio, Eduardo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; PLACEBO; STEROID;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; GRIP STRENGTH; HOSPITAL COST; HUMAN; LENGTH OF STAY; LOADING DRUG DOSE; LONG TERM CARE; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PLASMAPHERESIS; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 48949116959     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0788     Document Type: Short Survey

References (6)

1. Lunn MPT et al. (1999) Chronic inflammatory demyelinating polyradiculoneuropathy: A prevalence study in south east England. J Neurol Neurosurg Psychiatry 66: 677-680
2. Mehndiratta MM and Hughes RAC (2001) Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No.: CD002062. doi:10.1002/ 14651858.CD002062
3. Mehndiratta MM et al. (2004) Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003906. doi:10.1002/ 14651858.CD003906.pub2
4. van Schaik IN et al. (2002) Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD001797. doi:10.1002/ 14651858.CD001797
5. Joint Task Force of the EFNS and the PNS (2005) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. J Periph Nerv Sys 10: 220-228
6. McCrone P et al. (2003) Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Eur J Neurol 10: 687-694